The reduction in AP pathology by HJC0152 was also reflected in the markedly reduced levels of proinflammatory cytokines (TNFα, IL-6, IL-1β, IL-17A) compared to the non-treated pancreas (Figure 6H). This evidence concerns the gene IL17A and alkaline phosphatase measurement.